query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_1571_ESMFold_hypothetical_protein	4hzu-assembly1.cif.gz_S	LOKIASV2_1571_ESMFold_hypothetical_protein	4hzu-assembly1.cif.gz_S Structure of a bacterial energy-coupling factor transporter	0.270	173	117	24	196	2	162	6.476E-07	312
LOKIASV2_1571_ESMFold_hypothetical_protein	5kc4-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5kc4-assembly1.cif.gz_A Structure of TmRibU, orthorhombic crystal form	0.189	161	127	32	188	2	162	8.996E-04	179
LOKIASV2_1571_ESMFold_hypothetical_protein	4dve-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4dve-assembly1.cif.gz_A Crystal structure at 2.1 A of the S-component for biotin from an ECF-type ABC transporter	0.201	178	135	26	195	1	178	1.457E-03	147
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly2.cif.gz_C Crystal structure of FolT bound with folic acid	0.144	154	128	36	189	5	155	2.634E-02	121
LOKIASV2_1571_ESMFold_hypothetical_protein	5d0y-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5d0y-assembly2.cif.gz_B Substrate bound S-component of folate ECF transporter	0.160	151	122	35	185	3	148	3.875E-02	113
LOKIASV2_1571_ESMFold_hypothetical_protein	4mhw-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4mhw-assembly1.cif.gz_A Crystal structure of ThiT with small molecule BAT-25	0.163	171	139	35	205	5	171	3.692E-02	99
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_A Crystal structure of FolT bound with folic acid	0.186	158	127	33	189	2	159	2.901E-02	97
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly1.cif.gz_B Crystal structure of FolT bound with folic acid	0.171	149	120	36	184	6	151	4.267E-02	95
LOKIASV2_1571_ESMFold_hypothetical_protein	4huq-assembly1.cif.gz_S	LOKIASV2_1571_ESMFold_hypothetical_protein	4huq-assembly1.cif.gz_S Crystal Structure of a transporter	0.139	168	133	34	201	3	157	4.478E-02	94
LOKIASV2_1571_ESMFold_hypothetical_protein	7nnt-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7nnt-assembly1.cif.gz_C Cryo-EM structure of the folate-specific ECF transporter complex in DDM micelles	0.140	169	136	36	204	7	165	8.385E-02	89
LOKIASV2_1571_ESMFold_hypothetical_protein	4tkr-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4tkr-assembly1.cif.gz_A Native-SAD phasing for ThiT from Listeria monocytogenes serovar.	0.197	178	139	32	205	3	180	6.913E-02	80
LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly3.cif.gz_E	LOKIASV2_1571_ESMFold_hypothetical_protein	4z7f-assembly3.cif.gz_E Crystal structure of FolT bound with folic acid	0.147	153	119	36	188	2	141	1.516E+00	54
LOKIASV2_1571_ESMFold_hypothetical_protein	5mg3-assembly1.cif.gz_F	LOKIASV2_1571_ESMFold_hypothetical_protein	5mg3-assembly1.cif.gz_F EM fitted model of bacterial holo-translocon	0.106	162	139	29	190	132	288	1.752E+00	36
LOKIASV2_1571_ESMFold_hypothetical_protein	1h9u-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1h9u-assembly1.cif.gz_A The structure of the human retinoid-X-receptor beta ligand binding domain in complex with the specific synthetic agonist LG100268	0.142	178	132	28	205	43	197	5.244E-01	35
LOKIASV2_1571_ESMFold_hypothetical_protein	5kom-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5kom-assembly1.cif.gz_A The crystal structure of fluoride channel Fluc Ec2 F83I Mutant	0.159	163	102	30	192	2	123	1.590E+00	34
LOKIASV2_1571_ESMFold_hypothetical_protein	7qsd-assembly1.cif.gz_Y	LOKIASV2_1571_ESMFold_hypothetical_protein	7qsd-assembly1.cif.gz_Y Bovine complex I in the active state at 3.1 A	0.166	116	89	67	182	18	125	3.790E+00	34
LOKIASV2_1571_ESMFold_hypothetical_protein	6zkr-assembly1.cif.gz_V	LOKIASV2_1571_ESMFold_hypothetical_protein	6zkr-assembly1.cif.gz_V Native complex I, open3	0.145	116	88	67	182	22	125	3.612E+00	33
LOKIASV2_1571_ESMFold_hypothetical_protein	3zta-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	3zta-assembly1.cif.gz_A-2 The bacterial stressosome: a modular system that has been adapted to control secondary messenger signaling	0.105	131	110	71	201	5	128	2.838E+00	33
LOKIASV2_1571_ESMFold_hypothetical_protein	5lq3-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	5lq3-assembly2.cif.gz_D Structures and transport dynamics of the Campylobacter jejuni multidrug efflux pump CmeB	0.127	165	133	29	193	340	492	1.752E+00	33
LOKIASV2_1571_ESMFold_hypothetical_protein	5h46-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5h46-assembly1.cif.gz_A Mycobacterium smegmatis Dps1 mutant - F47E	0.103	160	132	26	185	1	148	2.124E+00	32
LOKIASV2_1571_ESMFold_hypothetical_protein	4zva-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4zva-assembly1.cif.gz_B Crystal structure of globin domain of the E. coli DosC - form I (ferric)	0.069	163	126	25	187	13	148	3.279E+00	32
LOKIASV2_1571_ESMFold_hypothetical_protein	2rld-assembly1.cif.gz_E	LOKIASV2_1571_ESMFold_hypothetical_protein	2rld-assembly1.cif.gz_E CRYSTAL STRUCTURE OF A PROTEIN WITH UNKNOWN FUNCTION FROM S23 RIBOSOMAL PROTEIN FAMILY (BT_0352) FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 1.70 A RESOLUTION	0.057	120	97	66	185	3	106	8.606E+00	31
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly2.cif.gz_C Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	0.118	177	129	30	206	53	199	8.915E-01	31
LOKIASV2_1571_ESMFold_hypothetical_protein	2p4y-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2p4y-assembly1.cif.gz_B Crystal structure of human PPAR-gamma-ligand binding domain complexed with an indole-based modulator	0.097	181	141	26	206	71	227	6.674E-01	31
LOKIASV2_1571_ESMFold_hypothetical_protein	8qee-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8qee-assembly1.cif.gz_A S. cerevisia Niemann-Pick type C protein NCR1 in Peptidisc at pH 7.5	0.165	167	138	31	196	234	400	4.824E+00	31
LOKIASV2_1571_ESMFold_hypothetical_protein	7rr8-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rr8-assembly1.cif.gz_C Multidrug efflux pump subunit AcrB	0.142	161	130	29	189	338	489	2.024E+00	31
LOKIASV2_1571_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5die-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a trifluoro-substituted A-CD ring estrogen derivative (1S,3aR,5S,7aS)-7a-methyl-5-(2,3,5-trifluoro-4-hydroxyphenyl)octahydro-1H-inden-1-ol	0.067	180	151	26	205	64	226	2.455E+00	30
LOKIASV2_1571_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6b24-assembly1.cif.gz_A Crystal structure of fluoride channel Fluc Ec2 F80Y Mutant	0.147	163	103	30	192	2	123	3.279E+00	29
LOKIASV2_1571_ESMFold_hypothetical_protein	6zkb-assembly1.cif.gz_V	LOKIASV2_1571_ESMFold_hypothetical_protein	6zkb-assembly1.cif.gz_V Membrane domain of closed complex I during turnover	0.110	116	92	67	182	22	125	5.575E+00	29
LOKIASV2_1571_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dkb-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-methylphenylamino-substituted ethyl triaryl-ethylene derivative 4,4'-(2-{3-[(3-methylphenyl)amino]phenyl}but-1-ene-1,1-diyl)diphenol	0.073	175	142	26	200	65	218	3.125E+00	29
LOKIASV2_1571_ESMFold_hypothetical_protein	1l2i-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1l2i-assembly2.cif.gz_A Human Estrogen Receptor alpha Ligand-binding Domain in Complex with (R,R)-5,11-cis-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol and a Glucocorticoid Receptor Interacting Protein 1 NR box II Peptide	0.079	171	132	30	200	76	219	3.441E+00	29
LOKIASV2_1571_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1sj0-assembly1.cif.gz_A-2 Human Estrogen Receptor Alpha Ligand-binding Domain in Complex with the Antagonist Ligand 4-D	0.108	221	178	6	205	21	241	1.516E+00	29
LOKIASV2_1571_ESMFold_hypothetical_protein	6qc4-assembly1.cif.gz_AK	LOKIASV2_1571_ESMFold_hypothetical_protein	6qc4-assembly1.cif.gz_AK Ovine respiratory supercomplex I+III2 open class 3	0.148	116	88	67	182	23	126	4.380E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_B Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	0.074	169	139	27	195	40	190	1.752E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjs-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5hjs-assembly1.cif.gz_A Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	0.097	178	141	28	205	62	218	2.024E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	0.103	171	138	30	200	59	213	3.441E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.084	201	169	17	201	24	224	3.125E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.071	183	156	19	187	25	207	2.455E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly1.cif.gz_A Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid	0.133	161	126	25	185	59	204	1.135E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1r5k-assembly2.cif.gz_C-2 Human Estrogen Receptor alpha Ligand-Binding Domain In Complex With GW5638	0.067	167	142	30	196	68	220	4.380E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly1.cif.gz_D LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.101	177	143	30	206	67	226	1.929E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	1hg4-assembly2.cif.gz_F	LOKIASV2_1571_ESMFold_hypothetical_protein	1hg4-assembly2.cif.gz_F Ultraspiracle ligand binding domain from Drosophila melanogaster	0.130	177	151	27	203	62	236	1.838E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	0.074	191	156	19	187	36	226	2.455E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_B 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides	0.094	176	141	26	201	96	252	1.669E+00	28
LOKIASV2_1571_ESMFold_hypothetical_protein	8olt-assembly1.cif.gz_Y	LOKIASV2_1571_ESMFold_hypothetical_protein	8olt-assembly1.cif.gz_Y Mitochondrial complex I from Mus musculus in the active state bound with piericidin A	0.155	120	88	67	186	21	125	9.032E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	4zvb-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	4zvb-assembly2.cif.gz_D Crystal structure of globin domain of the E. coli DosC - form II (ferrous)	0.057	157	136	29	185	2	146	5.313E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	6lit-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6lit-assembly1.cif.gz_B Estrogen-related receptor beta(ERR2) in complex with BPA	0.085	186	157	29	201	11	196	1.444E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	6jnr-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6jnr-assembly1.cif.gz_A RXRa structure complexed with CU-6PMN and SRC1 peptide.	0.115	172	125	30	201	57	198	1.838E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	1xdk-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1xdk-assembly1.cif.gz_A Crystal Structure of the RARbeta/RXRalpha Ligand Binding Domain Heterodimer in Complex with 9-cis Retinoic Acid and a Fragment of the TRAP220 Coactivator	0.111	180	138	27	206	52	207	1.752E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	3ipq-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	3ipq-assembly1.cif.gz_A-2 X-ray structure of GW3965 synthetic agonist bound to the LXR-alpha	0.090	172	135	28	199	57	205	2.838E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	5avi-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5avi-assembly1.cif.gz_C Crystal structure of LXRalpha in complex with tert-butyl benzoate analog, compound 4	0.112	159	123	26	184	61	200	1.444E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	0.097	175	143	26	200	66	224	5.062E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly2.cif.gz_B X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity	0.115	176	137	26	201	83	238	2.024E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	0.062	200	166	19	196	31	230	3.790E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	2har-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2har-assembly1.cif.gz_A Crystal structure of VDR LBD in complex with 2 alpha-(3-hydroxy-1-propoxy) calcitriol	0.085	200	166	25	206	41	240	1.376E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	1u77-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1u77-assembly1.cif.gz_A Crystal Structure of Ammonia Channel AmtB from E. Coli	0.132	163	135	39	201	224	380	3.279E+00	27
LOKIASV2_1571_ESMFold_hypothetical_protein	7v2c-assembly1.cif.gz_V	LOKIASV2_1571_ESMFold_hypothetical_protein	7v2c-assembly1.cif.gz_V Active state complex I from Q10 dataset	0.166	123	92	72	182	4	126	6.762E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	2iu5-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2iu5-assembly1.cif.gz_B Dihydroxyacetone kinase operon activator DhaS	0.115	173	131	32	180	2	174	3.612E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	2jsw-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2jsw-assembly1.cif.gz_A Solution Structure of the R13 Domain of Talin	0.096	179	146	27	189	3	181	6.762E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tbp-assembly1.cif.gz_A Crystal Structure of RXR-alpha ligand binding domain complexed with synthetic modulator K8003	0.113	176	146	28	203	31	196	1.444E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	7a78-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	7a78-assembly1.cif.gz_A-2 Crystal structure of RXR beta LBD in complexes with palmitic acid and GRIP-1 peptide	0.133	172	122	30	201	56	197	2.124E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	3os9-assembly1.cif.gz_C Estrogen Receptor	0.089	170	137	30	199	59	209	4.824E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5kcf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with an N-ethyl, 4-methoxybenzyl OBHS-N derivative	0.100	199	166	17	201	26	224	4.824E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	7wmo-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7wmo-assembly1.cif.gz_A A novel chemical derivative(92) of THRB agonist	0.090	171	134	30	200	74	221	3.125E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	4mg6-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4mg6-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with benzylbutylphtalate	0.080	177	142	26	202	66	220	3.790E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	5m24-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5m24-assembly1.cif.gz_A RARg mutant-S371E	0.120	154	116	34	187	79	211	2.577E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxm-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dxm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 3-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(4-hydroxyphenyl)methyl]phenol	0.082	160	130	26	185	66	208	5.851E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4pps-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with an A-CD ring estrogen derivative	0.069	175	147	26	200	65	223	5.313E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.069	162	135	26	187	66	211	3.977E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	1qku-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1qku-assembly1.cif.gz_A WILD TYPE ESTROGEN NUCLEAR RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH ESTRADIOL	0.069	188	158	30	200	46	233	5.575E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3r8a-assembly1.cif.gz_A X-ray crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a compound with dual PPAR gamma agonism and Angiotensin II Type I receptor antagonism activity	0.108	181	140	26	206	90	247	2.229E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	8jr9-assembly1.cif.gz_R	LOKIASV2_1571_ESMFold_hypothetical_protein	8jr9-assembly1.cif.gz_R Small molecule agonist (PCO371) bound to human parathyroid hormone receptor type 1 (PTH1R)	0.113	154	134	35	186	3	156	7.096E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgq-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dgq-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10506	0.101	174	134	26	199	91	240	2.229E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	7b5p-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7b5p-assembly1.cif.gz_C AcrB in cycloalkane amphipol	0.127	161	132	29	189	337	488	4.597E+00	26
LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_C Complex Structure of LXR with an agonist	0.089	161	118	29	189	53	183	3.790E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5dvv-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5dvv-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Triaryl-imine analog 4,4'-(phenylcarbonimidoyl)diphenol	0.125	175	134	27	201	53	206	3.612E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	1mv9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1mv9-assembly1.cif.gz_A Crystal Structure of the human RXR alpha ligand binding domain bound to the eicosanoid DHA (Docosa Hexaenoic Acid) and a coactivator peptide	0.122	172	124	30	201	56	197	2.577E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3uvv-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3uvv-assembly1.cif.gz_B Crystal Structure of the ligand binding domains of the thyroid receptor:retinoid X receptor complexed with 3,3',5 triiodo-L-thyronine and 9-cis retinoic acid	0.112	177	130	30	206	62	208	2.455E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.083	178	154	19	187	25	202	2.455E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complexed to a SERM	0.129	172	147	30	201	53	222	3.279E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3ips-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3ips-assembly1.cif.gz_A X-ray structure of benzisoxazole synthetic agonist bound to the LXR-alpha	0.075	172	137	28	199	60	208	2.704E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	7tut-assembly1.cif.gz_6	LOKIASV2_1571_ESMFold_hypothetical_protein	7tut-assembly1.cif.gz_6 Structure of the rabbit 80S ribosome stalled on a 4-TMD Rhodopsin intermediate in complex with the multipass translocon	0.085	187	145	28	187	32	218	6.443E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	5jy3-assembly2.cif.gz_D CRYSTAL STRUCTURE OF LXRbeta (NUCLEAR RECEPTOR SUBFAMILY 1, GROUP H, MEMBER 2) COMPLEXED WITH BMS-852927	0.106	174	143	27	200	65	225	1.838E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly1.cif.gz_A Human LRH1 LBD bound to GR470	0.126	171	128	30	200	72	218	3.790E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.081	176	140	30	205	72	224	5.851E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.076	176	157	30	205	57	227	5.313E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5krf-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Dynamic WAY derivative, 1a	0.088	181	144	26	206	66	224	4.824E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly2.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.089	174	136	26	199	72	221	3.279E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tmt-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 4,4'-((1,3-dihydro-2H-inden-2-ylidene)methylene)diphenol	0.063	175	146	26	200	66	222	4.380E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3x1i-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3x1i-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 6-oxo-tetracosahexaenoic acid	0.078	180	140	26	205	81	233	1.669E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4mg7-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with ferutinine	0.092	200	167	18	202	24	223	3.612E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 4-HDHA	0.094	174	141	27	200	82	238	2.024E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	1zdt-assembly3.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1zdt-assembly3.cif.gz_B-2 The Crystal Structure of Human Steroidogenic Factor-1	0.131	171	136	30	200	79	236	2.229E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	5krm-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5krm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol	0.074	175	147	26	200	65	224	6.140E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3fal-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	3fal-assembly1.cif.gz_D humanRXR alpha & mouse LXR alpha complexed with Retenoic acid and GSK2186	0.077	157	127	28	184	79	217	3.125E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1gwq-assembly1.cif.gz_B HUMAN OESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RALOXIFENE CORE AND TIF2 NRBOX2 PEPTIDE	0.076	171	141	30	200	74	227	6.443E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	4xta-assembly3.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	4xta-assembly3.cif.gz_B-2 MECHANISMS OF PPARgamma ACTIVATION BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS	0.100	176	133	26	201	80	228	2.024E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.096	158	134	30	187	69	217	4.174E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv3-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2vv3-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 4-oxoDHA	0.082	175	143	26	200	88	244	1.838E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly2.cif.gz_B Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist	0.103	178	135	27	204	99	250	1.838E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	6zly-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6zly-assembly1.cif.gz_A Crystal structure of the complex between PPARgamma LBD and the ligand NV1362 (7a)	0.101	174	135	26	199	87	237	2.577E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3x1h-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3x1h-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 5-oxo-tricosahexaenoic acid	0.082	174	144	27	200	96	253	2.340E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	6kay-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6kay-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-GW7647 co-crystals obtained by soaking	0.104	174	134	26	199	90	240	3.125E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly2.cif.gz_B Molecular recognition of nitro-fatty acids by PPAR gamma	0.087	179	138	26	204	93	244	2.024E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	3b9w-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3b9w-assembly1.cif.gz_A The 1.3 A resolution structure of Nitrosomonas europaea Rh50 and mechanistic implications for NH3 transport by Rhesus family proteins	0.148	168	139	31	198	177	340	4.380E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	6ows-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6ows-assembly1.cif.gz_C Cryo-EM structure of an Acinetobacter baumannii multidrug efflux pump	0.125	156	123	30	185	864	1004	3.612E+00	25
LOKIASV2_1571_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7pdt-assembly1.cif.gz_A Crystal structure of a mutated form of RXRalpha ligand binding domain in complex with BMS649 and a coactivator fragment	0.126	197	155	29	206	5	201	1.444E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7aos-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7aos-assembly1.cif.gz_A crystal structure of the RARalpha/RXRalpha ligand binding domain heterodimer in complex with a fragment of SRC1 coactivator	0.132	157	120	27	183	57	195	2.577E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_B crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen	0.111	178	156	31	206	39	216	3.977E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5dxq-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(1s,5s)-bicyclo[3.3.1]non-9-ylidenemethanediyl]diphenol	0.083	176	136	30	205	70	218	8.201E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	2yat-assembly1.cif.gz_A-2 Crystal structure of estradiol derived metal chelate and estrogen receptor-ligand binding domain complex	0.086	158	118	30	187	70	199	7.096E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7wqq-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7wqq-assembly1.cif.gz_A Retinoic acid receptor alpha mutant - N299H	0.106	168	131	31	198	69	215	5.062E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_B Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.125	177	141	30	206	70	231	3.612E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	4dk8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4dk8-assembly1.cif.gz_A Crystal structure of LXR ligand binding domain in complex with partial agonist 5	0.097	173	144	28	200	71	231	3.977E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8daf-assembly2.cif.gz_B Human SF-1 LBD bound to synthetic agonist 6N-10CA and bacterial phospholipid	0.118	156	118	30	185	75	209	2.455E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	5dke-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dke-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a 3-naphthyl-substituted, methyl, cis-diaryl-ethylene compound 4,4'-[2-(naphthalen-2-yl)prop-1-ene-1,1-diyl]diphenol	0.051	185	172	4	185	19	203	3.790E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.069	201	175	17	205	24	224	6.140E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	0.099	210	164	19	201	26	235	2.577E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_A Crystal structure of ERa LBD in complex with RU100132	0.075	201	173	18	205	26	226	6.140E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	4ple-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	4ple-assembly2.cif.gz_C Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to an E. Coli Phospholipid and a Fragment of TIF-2	0.123	167	125	30	196	81	224	3.279E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.080	189	156	17	187	26	214	4.380E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	0.102	177	147	26	202	76	240	3.977E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	1pk5-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1pk5-assembly1.cif.gz_A Crystal structure of the orphan nuclear receptor LRH-1	0.104	202	161	21	201	38	239	2.455E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	1zh7-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1zh7-assembly2.cif.gz_B Structural and Biochemical Basis for Selective Repression of the Orphan Nuclear Receptor LRH-1 by SHP	0.122	174	140	30	203	81	241	3.441E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	4l98-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4l98-assembly1.cif.gz_A Crystal structure of the complex of F360L PPARgamma mutant with the ligand LT175	0.100	175	133	30	204	79	227	2.838E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	2q5g-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2q5g-assembly1.cif.gz_A Ligand binding domain of PPAR delta receptor in complex with a partial agonist	0.113	174	127	30	203	94	237	3.125E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs4-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-8	0.055	191	159	19	187	28	218	5.062E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7bju-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7bju-assembly1.cif.gz_A Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI08346	0.106	173	136	35	187	45	217	1.590E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly3.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly3.cif.gz_C Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	0.135	159	119	29	187	83	221	2.978E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	6kxy-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6kxy-assembly1.cif.gz_A Human PPAR alpha ligand binding domain in complex with a synthetic agonist (compound B)	0.114	179	134	26	204	86	237	2.978E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	6l96-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6l96-assembly1.cif.gz_B Structure of PPARalpha-LBD/pemafibrate/SRC1 peptide	0.111	169	127	31	199	94	237	3.125E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2q6s-assembly1.cif.gz_A 2.4 angstrom crystal structure of PPAR gamma complexed to BVT.13 without co-activator peptides	0.100	174	135	26	199	89	239	2.978E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602	0.112	174	133	26	199	92	242	3.441E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	6e5a-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6e5a-assembly1.cif.gz_A PPARg in complex with compound 4b	0.074	171	140	26	196	92	243	3.125E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	4c9q-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4c9q-assembly2.cif.gz_B Structure of yeast mitochondrial ADP/ATP carrier isoform 3 inhibited by carboxyatractyloside (P21 crystal form)	0.118	201	147	29	196	85	285	7.447E+00	24
LOKIASV2_1571_ESMFold_hypothetical_protein	5ww9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5ww9-assembly1.cif.gz_A Crystal structure of R73E mutant of the second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.086	181	142	3	183	1	156	7.447E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_C Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	0.116	175	133	27	201	43	193	3.441E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly2.cif.gz_F	LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly2.cif.gz_F Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.127	175	132	27	201	45	196	4.174E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly3.cif.gz_D-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1pq6-assembly3.cif.gz_D-2 HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX	0.106	177	144	26	202	65	226	4.174E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.074	190	161	19	193	25	214	2.838E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6vgh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6vgh-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant In Complex with Lasofoxifene	0.115	203	158	22	200	24	226	2.577E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly1.cif.gz_A Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.115	171	139	30	200	70	227	5.313E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5tm2-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5tm2-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 2,5-bis(2-chloro-4-hydroxyphenyl)thiophene 1-oxide	0.078	177	147	24	200	61	220	7.096E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6psj-assembly1.cif.gz_A Bazedoxifene in Complex with Y537S Estrogen Receptor Alpha Ligand Binding Domain	0.129	177	146	30	206	64	232	4.824E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	4rak-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4rak-assembly1.cif.gz_B Crystal structure of nuclear receptor subfamily 1, group h, member 2 (lxrb) complexed with partial agonist	0.065	207	145	26	181	2	208	2.124E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.082	176	151	30	205	59	224	6.443E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5duh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Sulfoxide-bridged Oxabicyclic Heptene Sulfonate (SOBHS)-3 analog phenyl (1S,2S,4S,7S)-5,6-bis(4-hydroxy-3-methylphenyl)-7-thiabicyclo[2.2.1]hept-5-ene-2-sulfonate 7-oxide	0.052	178	161	30	200	40	217	6.443E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	2pog-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2pog-assembly1.cif.gz_A Benzopyrans as Selective Estrogen Receptor b Agonists (SERBAs). Part 2: Structure Activity Relationship Studies on the Benzopyran Scaffold.	0.134	178	145	29	206	66	233	3.977E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.093	210	170	19	206	23	232	4.824E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly3.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4n-assembly3.cif.gz_B LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.098	177	137	30	206	72	224	4.174E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.056	200	176	19	205	25	224	6.762E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	3os8-assembly1.cif.gz_C Estrogen Receptor	0.095	176	146	30	205	60	221	5.851E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5drm-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a dichloro-substituted, 2,5-diarylthiophene-core ligand 4,4'-thiene-2,5-diylbis(3-chlorophenol)	0.085	172	145	26	197	61	220	8.606E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4iw6-assembly1.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 7b	0.079	175	142	26	200	66	220	9.478E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	0.111	158	140	30	187	59	216	3.977E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4ivw-assembly3.cif.gz_B Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 6b	0.080	175	144	26	200	67	223	8.201E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	0.069	175	148	26	200	64	223	7.447E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujm-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative That Increases Receptor Resonance Time in the Nucleus of Breast Cancer Cells	0.082	176	155	30	205	56	225	7.096E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4mgb-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with TCBPA	0.085	171	136	30	200	76	225	9.032E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	1pcg-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1pcg-assembly1.cif.gz_B Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions	0.096	177	142	30	206	77	234	7.096E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly2.cif.gz_B Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	0.116	158	122	30	187	79	217	3.790E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6md2-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6md2-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Arachidonic acid	0.085	173	140	26	198	90	243	3.612E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6dh9-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with MSDC-0602	0.088	176	142	26	201	96	252	3.441E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6lxc-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6lxc-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-saroglitazar co-crystals obtained by delipidation and cross-seeding	0.120	179	133	26	204	89	240	3.612E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	4xuh-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4xuh-assembly2.cif.gz_B PPARgamma ligand binding domain in complex with sulindac sulfide	0.088	170	133	26	195	94	240	3.977E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgr-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dgr-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with CAY10638	0.086	181	143	26	206	94	251	3.612E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	3vjh-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3vjh-assembly1.cif.gz_A Human PPAR GAMMA ligand binding domain in complex with JKPL35	0.103	181	141	26	206	94	251	3.612E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	2npd-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2npd-assembly1.cif.gz_A An unusual twin-His arrangement in the pore of ammonia channels is essential for substrate conductance	0.132	166	132	39	204	211	363	6.140E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	8tid-assembly1.cif.gz_K	LOKIASV2_1571_ESMFold_hypothetical_protein	8tid-assembly1.cif.gz_K Combined linker domain of N-DRC and associated proteins Tetrahymena	0.106	228	181	1	204	1	228	4.380E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6npl-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6npl-assembly1.cif.gz_A Cryo-EM structure of NKCC1	0.129	147	112	30	176	25	154	4.380E+00	23
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_B RXRa structure complexed with CU-6PMN	0.122	174	135	30	203	39	193	2.577E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	0.053	172	161	30	200	36	207	5.062E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_B Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.116	175	133	27	201	45	196	4.597E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5e15-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	0.045	169	159	30	198	35	201	7.096E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5tn9-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-5-(4-hydroxyphenyl)-6-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.062	180	158	19	187	24	203	5.062E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	5u2b-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol, without a coactivator peptide	0.062	175	152	25	187	24	198	4.824E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	2e2r-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2e2r-assembly1.cif.gz_A Crystal structure of human estrogen-related receptor gamma ligand binding domain complex with bisphenol A	0.089	175	151	30	196	37	211	5.062E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5y-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6a5y-assembly1.cif.gz_A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC143 and 9cRA and SRC1	0.117	175	139	26	200	68	225	5.851E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5krl-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5krl-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the A-CD ring estrogen, (1S,7aS)-5-(2-chloro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1H-inden-1-ol	0.067	179	146	27	205	62	219	9.947E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.088	191	167	17	200	26	216	8.201E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5dwj-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dwj-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with a Resorcinyl 4-Fluoro-substituted Diaryl-imine analog 4-[(E)-[(4-fluorophenyl)imino](4-hydroxyphenyl)methyl]benzene-1,3-diol	0.064	177	139	26	202	65	213	6.443E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	1nde-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1nde-assembly1.cif.gz_A Estrogen Receptor beta with Selective Triazine Modulator	0.086	174	145	30	203	70	229	6.140E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.076	203	173	18	205	20	222	7.096E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_C Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.125	177	144	30	206	70	234	4.380E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3ipu-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3ipu-assembly1.cif.gz_B X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha	0.106	179	138	28	206	72	226	3.612E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4iu7-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor alpha Ligand-binding Domain in Complex with Constrained WAY-derivative, 2b	0.080	176	152	26	201	67	232	5.313E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1x7r-assembly1.cif.gz_A-2 CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA COMPLEXED WITH GENISTEIN	0.117	172	146	30	201	68	233	4.824E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5krh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5krh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with 16-benzylidene estrone	0.098	197	162	20	200	26	222	7.815E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_B HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	0.083	213	149	26	188	2	214	2.838E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3osa-assembly1.cif.gz_A Estrogen Receptor	0.097	158	135	30	187	67	217	8.201E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5dlr-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dlr-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a triaryl-ethylene compound 4,4'-(2-phenylethene-1,1-diyl)diphenol	0.084	183	154	17	185	26	208	7.096E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_A X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol	0.091	159	126	26	184	74	213	4.380E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	4dos-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4dos-assembly1.cif.gz_A Human Nuclear Receptor Liver Receptor Homologue-1, LRH-1, Bound to DLPC and a Fragment of TIF-2	0.132	172	137	30	201	83	241	3.441E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_B Human LXR-beta in complex with a ligand	0.100	155	122	30	184	71	207	5.313E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs0-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-18	0.090	204	165	19	200	26	229	3.279E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5tms-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5tms-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the Cyclofenil-ASC derivative, ethyl (E)-3-(4-(bicyclo[3.3.1]nonan-9-ylidene(4-hydroxyphenyl)methyl)phenyl)acrylate	0.080	200	166	20	200	29	228	8.606E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	2xhs-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2xhs-assembly1.cif.gz_A Crystal structure of the ligand binding domain of Fushi tarazu factor 1 of Drosophila melanogaster.	0.072	157	132	25	181	74	216	5.062E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly2.cif.gz_D Human LXR-beta in complex with a ligand	0.103	159	125	26	184	73	212	4.824E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7bjv-assembly1.cif.gz_A Crystal structure of the ligand-binding domains of the heterodimer EcR/USP bound to the synthetic agonist BYI09181	0.112	159	121	29	187	82	218	4.174E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	2j4a-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2j4a-assembly1.cif.gz_A Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084	0.086	205	174	15	205	36	240	5.062E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	2hwq-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2hwq-assembly1.cif.gz_B Structural basis for the structure-activity relationships of Peroxisome Proliferator-Activated Receptor agonists	0.087	178	138	27	204	95	246	3.279E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5tto-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	5tto-assembly1.cif.gz_B-2 X-ray crystal structure of PPARgamma in complex with SR1643	0.107	173	133	26	198	92	241	4.597E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	2b50-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2b50-assembly1.cif.gz_A Human Nuclear Receptor-Ligand Complex 2	0.089	174	136	26	199	94	243	4.597E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3an4-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3an4-assembly2.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO4R	0.090	180	161	29	206	73	252	3.977E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3an3-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3an3-assembly2.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist MO3S	0.107	174	134	26	199	96	246	4.597E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	7c6q-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7c6q-assembly1.cif.gz_A Novel natural PPARalpha agonist with a unique binding mode	0.092	179	137	26	204	96	247	3.977E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6lx4-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6lx4-assembly2.cif.gz_B X-ray structure of human PPARalpha ligand binding domain-fenofibric acid co-crystals obtained by delipidation and co-crystallization	0.098	179	136	26	204	100	251	4.174E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3cs8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3cs8-assembly1.cif.gz_A Structural and Biochemical Basis for the Binding Selectivity of PPARg to PGC-1a	0.109	162	124	26	187	102	241	4.824E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6ivp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6ivp-assembly1.cif.gz_A Crystal structure of a membrane protein P262A	0.096	172	147	29	200	34	197	6.762E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3adw-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3adw-assembly1.cif.gz_A Human PPARgamma ligand-binding domain in complex with 5-methoxy-indole acetate and 15-oxo-eicosatetraenoic acid	0.090	174	137	26	199	107	257	5.313E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbb-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6sbb-assembly2.cif.gz_B Structure of type II terpene cyclase MstE from Scytonema (apo)	0.113	158	106	26	183	1	120	3.279E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	4xnv-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4xnv-assembly1.cif.gz_A The human P2Y1 receptor in complex with BPTU	0.093	199	149	23	187	5	203	3.279E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	3b9y-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3b9y-assembly1.cif.gz_A Crystal structure of the Nitrosomonas europaea Rh protein	0.148	168	139	31	198	178	341	6.762E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	5iwk-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5iwk-assembly1.cif.gz_A Structure of Transient Receptor Potential (TRP) channel TRPV6	0.134	233	149	28	200	300	532	4.380E+00	22
LOKIASV2_1571_ESMFold_hypothetical_protein	4uiq-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4uiq-assembly2.cif.gz_A Isolated globin domain of the Bordetella pertussis globin-coupled sensor with a heme at the dimer interface	0.128	160	119	27	186	16	153	9.032E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	8h17-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8h17-assembly1.cif.gz_A Crystal structure of the Globin domain of Thermosynechococcus elongatus BP-1	0.088	160	140	30	189	2	156	5.851E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_A Crystal structure of gated-pore mutant D138N of second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.097	178	137	6	183	3	155	8.201E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	4m32-assembly1.cif.gz_C Crystal structure of gated-pore mutant D138N of second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.087	178	139	6	183	3	155	8.606E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4m35-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4m35-assembly1.cif.gz_A Crystal structure of gated-pore mutant H126/141D of second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.105	194	141	3	196	1	158	5.062E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_C RXRa structure complexed with CU-6PMN	0.089	186	157	29	201	3	188	3.279E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6suo-assembly1.cif.gz_B ERa_L536S (L536S/C381S/C471S,C530S) in complex with a tricyclic indole (compound 6)	0.098	181	158	25	200	18	198	4.174E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly1.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	0.082	184	158	26	198	24	207	5.575E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5ji0-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5ji0-assembly2.cif.gz_A PPARgamma-RXRalpha(S427F) heterodimer in complex with SRC-1, rosiglitazone, and 9-cis-retanoic acid	0.115	172	125	30	201	66	207	5.062E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3	LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_D-3 Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	0.103	183	153	30	201	32	214	7.447E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6pit-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6pit-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with SRC2 Stapled Peptide 41A and Estradiol	0.101	189	153	31	201	30	218	2.838E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1s9q-assembly1.cif.gz_A crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with 4-hydroxytamoxifen	0.115	177	153	30	203	37	213	4.380E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6zoq-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 16	0.098	199	161	23	201	25	223	3.441E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_A Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	0.077	192	165	26	205	28	219	7.096E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	0.089	201	167	18	201	26	226	5.313E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2iok-assembly1.cif.gz_B Human estrogen receptor alpha ligand-binding domain in complex with compound 1D	0.112	204	160	18	198	23	226	5.851E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	0.066	176	149	30	205	54	214	9.478E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2r6w-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain complexed to a SERM	0.098	204	160	27	204	25	228	6.762E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5jmm-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with biochanin A	0.076	192	169	17	200	25	216	9.478E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	0.097	176	135	30	205	70	219	7.815E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.092	176	150	30	205	58	223	7.096E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8ev1-assembly1.cif.gz_A Dual Modulators	0.076	195	158	30	201	41	235	4.380E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7n9o-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain in Complex with Aliphatic SERD S-C10(15)	0.084	176	153	30	205	58	225	3.790E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2qgt-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Complexed to an Ether Estradiol Compound	0.080	176	155	26	201	66	234	8.606E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_C-2	LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_C-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	0.064	200	175	18	205	25	224	7.096E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	8duk-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-(methylamino)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.079	216	172	19	206	23	238	4.597E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4mgc-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4mgc-assembly1.cif.gz_A Crystal structure of hERa-LBD (Y537S) in complex with benzophenone-2	0.072	198	167	20	200	25	222	9.032E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4t-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4t-assembly1.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.087	229	163	27	205	3	231	4.174E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5tmv-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS analog, 4-iodophenyl (1S,2R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.086	180	149	26	205	67	230	8.606E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6vjd-assembly2.cif.gz_C Estrogen Receptor Alpha Ligand Binding Domain in Complex with Lasofoxifene	0.089	205	167	22	205	24	228	6.443E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1yin-assembly1.cif.gz_A-2 Human estrogen receptor alpha ligand-binding domain in complex with compound 3F	0.128	216	167	13	205	24	239	5.851E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2acl-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2acl-assembly1.cif.gz_B Liver X-Receptor alpha Ligand Binding Domain with SB313987	0.122	226	155	27	204	4	229	4.597E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly2.cif.gz_E	LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly2.cif.gz_E Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.065	224	158	24	193	1	224	3.977E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 6-oxoOTE	0.088	174	142	27	200	89	245	4.597E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6t9c-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6t9c-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand NV1346 (3a)	0.109	168	128	31	198	89	233	5.575E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5u5l-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	5u5l-assembly1.cif.gz_B-2 X-ray Crystal Structure of the PPARgamma Ligand Binding Domain in Complex with Rivoglitazone	0.093	175	143	26	200	92	250	5.062E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6dha-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dha-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Hydroxy Pioglitazone (M-IV)	0.079	173	141	26	198	88	241	5.313E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2rew-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2rew-assembly1.cif.gz_A Crystal Structure of PPARalpha ligand binding domain with BMS-631707	0.086	180	139	25	204	87	239	5.062E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_A Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days.	0.095	174	136	26	199	94	244	5.313E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2xyj-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2xyj-assembly2.cif.gz_B Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy	0.096	151	118	34	184	98	228	4.174E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	3et1-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3et1-assembly1.cif.gz_A Structure of PPARalpha with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid	0.109	176	129	29	204	101	246	6.762E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	2xyw-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2xyw-assembly2.cif.gz_B Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy	0.083	178	138	29	206	102	253	5.313E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	1k7l-assembly4.cif.gz_G	LOKIASV2_1571_ESMFold_hypothetical_protein	1k7l-assembly4.cif.gz_G The 2.5 Angstrom resolution crystal structure of the human PPARalpha ligand binding domain bound with GW409544 and a co-activator peptide.	0.114	179	134	26	204	99	250	5.062E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5dv8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5dv8-assembly1.cif.gz_A Human PPARgamma ligand binding dmain complexed with SB1451 in a covalent bonded form	0.103	162	125	26	187	101	240	6.762E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	5vyd-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5vyd-assembly2.cif.gz_B Crystal structure of phosphodiesterase domain of RhoPDE fusion protein from the Choanoflagellate Salpingoeca rosetta	0.127	165	123	30	194	175	316	2.229E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	7prv-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7prv-assembly1.cif.gz_A The glucocorticoid receptor in complex with fluticasone furoate, a PGC1a coactivator fragment and sgk 23bp	0.071	206	172	20	205	92	297	6.140E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4k0j-assembly2.cif.gz_E	LOKIASV2_1571_ESMFold_hypothetical_protein	4k0j-assembly2.cif.gz_E X-ray crystal structure of a heavy metal efflux pump, crystal form I	0.146	171	126	31	201	804	952	9.478E+00	21
LOKIASV2_1571_ESMFold_hypothetical_protein	4a25-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4a25-assembly1.cif.gz_B X-ray structure Dps from Kineococcus radiotolerans in complex with Mn (II) ions.	0.087	158	128	26	183	21	161	9.032E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7cfo-assembly1.cif.gz_A Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.	0.143	177	140	27	203	30	193	3.612E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	8t06-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8t06-assembly1.cif.gz_B Structure of mouse Myomaker mutant-R107A bound to Fab18G7	0.101	136	112	45	180	2	127	8.201E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	8apy-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8apy-assembly1.cif.gz_A Crystal structure of the H12A variant of the KDEL receptor bound to sybody	0.112	203	145	27	190	1	203	5.575E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	0.090	166	143	30	187	35	200	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	1osh-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1osh-assembly1.cif.gz_A A Chemical, Genetic, and Structural Analysis of the nuclear bile acid receptor FXR	0.084	179	156	26	196	24	202	5.062E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.105	158	126	30	187	60	201	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7y8f-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7y8f-assembly2.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with an Inhibitor 30o and GRIP Peptide	0.087	181	146	27	187	30	210	7.815E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5yxj-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5yxj-assembly2.cif.gz_B FXR ligand binding domain	0.081	189	165	22	202	32	220	6.443E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6s5k-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6s5k-assembly1.cif.gz_A LXRbeta ligand binding domain in complex with small molecule inhibitors	0.097	170	135	27	196	59	209	9.032E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly2.cif.gz_H	LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly2.cif.gz_H Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1	0.112	151	132	30	180	48	197	5.062E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	0.104	176	140	30	205	58	214	5.313E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_C Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.064	182	164	30	205	34	215	5.313E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly2.cif.gz_B GDC-9545 in complex with estrogen receptor alpha	0.075	187	152	23	187	25	211	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tlg-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with (E)-4,4''-dihydroxy-3'-((hydroxyiminio)methyl)-[1,1':2',1''-terphenyl]-4'-olate	0.082	178	155	31	200	37	214	9.478E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol	0.086	209	151	35	200	7	215	8.606E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs1-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-21	0.102	208	165	17	201	25	232	6.443E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6zos-assembly1.cif.gz_B Oestrogen receptor ligand binding domain in complex with compound 18	0.110	158	133	30	187	63	212	9.478E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dz0-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-[(4-methylcyclohexylidene)methanediyl]diphenol	0.107	193	161	20	200	26	218	9.478E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_D GDC-9545 in complex with estrogen receptor alpha	0.075	197	161	19	193	25	221	5.062E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rrx-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-19	0.084	198	170	19	205	24	221	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly3.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly3.cif.gz_C LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.109	176	137	30	205	73	227	5.851E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4dma-assembly1.cif.gz_B Crystal structure of ERa LBD in complex with RU100132	0.062	181	146	26	206	68	224	9.947E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7tt8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7tt8-assembly1.cif.gz_A Human LRH-1 LBD bound to agonist 6N-10CA and fragment of Tif2 coactivator	0.126	157	115	30	186	76	208	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with a Methylated Lasofoxifene Derivative with Selective Estrogen Receptor Degrader Properties	0.098	180	159	30	206	56	235	7.815E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	1yok-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1yok-assembly1.cif.gz_A crystal structure of human LRH-1 bound with TIF-2 peptide and phosphatidylglycerol	0.095	191	159	20	196	31	221	5.062E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F	LOKIASV2_1571_ESMFold_hypothetical_protein	5kra-assembly2.cif.gz_F Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with DDT and DDE	0.085	176	153	26	201	66	233	7.447E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5krc-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with Zearalenone	0.062	196	169	20	200	26	221	9.478E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	1zky-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1zky-assembly1.cif.gz_A Human Estrogen Receptor Alpha Ligand-Binding Domain In Complex With OBCP-3M and A Glucocorticoid Receptor Interacting Protein 1 Nr Box II Peptide	0.083	179	157	26	204	67	238	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly1.cif.gz_A Human LXR-beta in complex with an agonist	0.118	156	117	30	185	71	204	5.575E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	0.093	194	158	13	187	25	218	8.201E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5kya-assembly1.cif.gz_A Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.069	235	165	24	201	1	235	3.977E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4tuz-assembly1.cif.gz_B Crystal structure of hERa-LBD (Y537S) in complex with alpha-zearalenol	0.078	167	139	30	196	76	227	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	3t03-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3t03-assembly2.cif.gz_B Crystal structure of PPAR gamma ligand binding domain in complex with a novel partial agonist GQ-16	0.125	181	134	26	206	85	238	6.443E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	1nav-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1nav-assembly1.cif.gz_A Thyroid Receptor Alpha in complex with an agonist selective for Thyroid Receptor Beta1	0.097	182	158	30	205	60	241	3.790E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	3d5f-assembly3.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3d5f-assembly3.cif.gz_B Crystal Structure of PPAR-delta complex	0.072	175	139	28	202	88	238	6.762E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	3g8i-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3g8i-assembly1.cif.gz_A Aleglitazar, a new, potent, and balanced PPAR alpha/gamma agonist for the treatment of type II diabetes	0.110	172	132	27	198	87	235	8.606E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2vv4-assembly1.cif.gz_A hPPARgamma Ligand binding domain in complex with 6-oxoOTE	0.107	174	134	26	199	88	238	7.447E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_B Crystal structure of hPPARgamma ligand binding domain complexed with rosiglitazone-based fluorescence probe	0.120	180	136	26	205	95	250	5.851E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6f2l-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand LJ570: structure obtained from crystals of the apo-form soaked for 15 days.	0.075	181	147	26	206	96	255	6.762E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	3fur-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3fur-assembly1.cif.gz_A Crystal Structure of PPARg in complex with INT131	0.095	176	134	29	204	91	239	5.851E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_A Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145	0.115	179	134	26	204	88	239	6.140E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	2xkw-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2xkw-assembly2.cif.gz_B LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST PIOGLITAZONE	0.098	175	143	26	200	96	254	5.851E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_B-2 Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907	0.087	175	145	26	200	96	255	5.851E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	3v9t-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3v9t-assembly1.cif.gz_A Crystal structure of the PPARgamma-LBD complexed with a cercosporamide derivative modulator	0.090	178	137	27	204	94	244	5.062E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5y7x-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5y7x-assembly1.cif.gz_A Human Peroxisome proliferator-activated receptor (PPAR) delta in complexed with a potent and selective agonist	0.069	157	123	31	187	99	231	8.201E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q61-assembly1.cif.gz_B Crystal Structure of PPARgamma ligand binding domain bound to partial agonist SR145	0.093	178	136	27	204	95	245	4.174E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	2zk0-assembly2.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	2zk0-assembly2.cif.gz_B-2 Human peroxisome proliferator-activated receptor gamma ligand binding domain	0.098	177	139	27	203	97	251	6.140E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	7qb1-assembly1.cif.gz_BBB	LOKIASV2_1571_ESMFold_hypothetical_protein	7qb1-assembly1.cif.gz_BBB PPARg in complex with inhibitor	0.102	173	134	27	199	97	246	7.096E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5y2t-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	5y2t-assembly1.cif.gz_B-2 Structure of PPARgamma ligand binding domain - lobeglitazone complex	0.120	179	133	26	204	97	248	6.762E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	6z12-assembly3.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6z12-assembly3.cif.gz_C Salmonella AcrB solubilised in the SMA copolymer	0.162	178	134	29	206	337	497	8.606E+00	20
LOKIASV2_1571_ESMFold_hypothetical_protein	5vot-assembly1.cif.gz_F	LOKIASV2_1571_ESMFold_hypothetical_protein	5vot-assembly1.cif.gz_F Structure of AMPA receptor-TARP complex	0.128	169	146	31	199	4	172	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5t97-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5t97-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH (2E)-3-(4-{(1R)-6-hydroxy-1-methyl-2-[4-(propan-2 -yl)phenyl]-1,2,3,4- tetrahydroisoquinolin-1-yl}phenyl)prop-2-enoic acid	0.084	161	143	31	187	25	185	9.947E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2q60-assembly1.cif.gz_A Crystal structure of the ligand binding domain of polyandrocarpa misakiensis rxr in tetramer in absence of ligand	0.107	162	129	28	189	42	186	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6jno-assembly1.cif.gz_D RXRa structure complexed with CU-6PMN	0.093	189	156	29	201	3	191	5.313E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5yxl-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	5yxl-assembly2.cif.gz_C A ligand M binding to FXR	0.092	153	136	30	180	38	190	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5hjp-assembly1.cif.gz_A Identification of LXRbeta selective agonists for the treatment of Alzheimer's Disease	0.112	195	157	29	206	4	198	3.790E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1s9p-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1s9p-assembly1.cif.gz_A crystal structure of the ligand-binding domain of the estrogen-related receptor gamma in complex with diethylstilbestrol	0.095	189	157	27	201	22	210	5.313E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.085	183	156	31	201	35	217	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8du9-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	0.088	158	138	30	187	50	201	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6pfm-assembly1.cif.gz_A Crystal structure of GDC-0927 bound to estrogen receptor alpha	0.078	194	157	17	187	24	217	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	7trb-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7trb-assembly1.cif.gz_A CRYSTAL STRUCTURE OF FARNESOID X-ACTIVATED RECEPTOR COMPLEXED WITH COMPOUND-32 AKA (1S,3S)-N-({4-[5-(2-FLUOROPR OPAN-2-YL)-1,2,4-OXADIAZOL-3-YL]BICYCLO[2.2.2]OCTAN-1-YL}M ETHYL)-3-HYDROXY-N-[4'-(2-HYDROXYPROPAN-2-YL)-[1,1'-BIPHEN YL]-3-YL]-3-(TRIFLUOROMETHYL)CYCLOBUTANE-1-CARBOXAMIDE	0.101	174	130	26	199	65	210	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1pzl-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1pzl-assembly1.cif.gz_A Crystal structure of HNF4a LBD in complex with the ligand and the coactivator SRC-1 peptide	0.098	180	141	27	206	60	216	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujy-assembly2.cif.gz_D Estrogen receptor alpha ligand binding domain Y537S mutant in complex with a methylated lasofoxifene derivative that enhances estrogen receptor alpha nuclear resonance time	0.097	171	139	30	200	72	226	9.947E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1qkn-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	1qkn-assembly1.cif.gz_A-2 RAT OESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH ANTAGONIST RALOXIFENE	0.105	187	153	30	201	41	227	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	4avm-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	4avm-assembly1.cif.gz_A-2 Crystal structure of the N-BAR domain of human bridging integrator 2.	0.097	174	155	29	201	48	221	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5tld-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tld-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the phenylamino-substituted estrogen, (8R,9S,13S,14S,17S)-13-methyl-17-(phenylamino)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	0.072	189	159	30	201	39	227	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6wok-assembly2.cif.gz_B Crystal structure of estrogen receptor alpha in complex with receptor degrader 6	0.099	187	153	17	187	25	211	5.851E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	0.095	174	141	27	200	61	217	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly1.cif.gz_A HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	0.082	226	164	26	205	1	226	5.313E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_A Estrogen receptor alpha ligand-binding domain in complex with a SERM	0.102	203	156	26	200	25	227	4.597E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	3kfc-assembly2.cif.gz_D Complex Structure of LXR with an agonist	0.082	231	160	26	200	1	231	5.062E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dzh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[4-(2-hydroxyethyl)cyclohexylidene]methanediyl}diphenol	0.075	180	153	20	185	26	205	9.032E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5gs4-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5gs4-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with a stabilized peptide antagonist	0.113	172	146	30	201	69	234	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6vpf-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with the Selective Estrogen Receptor Modulator Clomiphene	0.078	186	155	17	185	24	209	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs3-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-29	0.083	189	154	19	187	28	216	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1p8d-assembly3.cif.gz_B X-Ray Crystal Structure of LXR Ligand Binding Domain with 24(S),25-epoxycholesterol	0.103	179	135	26	204	75	226	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_A Estrogen receptor mutant L536S	0.071	156	141	30	185	55	207	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5dkg-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain in complex with a t-butyl-substituted, methyl, triaryl-ethylene derivative 4,4'-[2-(4-tert-butylphenyl)prop-1-ene-1,1-diyl]diphenol	0.114	211	163	17	201	26	236	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3plz-assembly2.cif.gz_B Human LRH1 LBD bound to GR470	0.100	176	149	30	196	48	223	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5t1z-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with Ethoxytriphenylethylene and GRIP Peptide	0.100	175	142	26	200	66	224	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5tm7-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5tm7-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the OBHS-ASC compound, 7-(4-((1R,4S,6R)-6-((3-chlorophenoxy)sulfonyl)-3-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-2-en-2-yl)phenoxy)heptanoic acid	0.107	164	121	66	201	74	237	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3l0e-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3l0e-assembly1.cif.gz_A X-ray crystal structure of a Potent Liver X Receptor Modulator	0.065	147	124	34	180	83	216	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2qab-assembly1.cif.gz_B Crystal Structure of Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with an Ethyl Indazole Compound	0.097	174	146	27	200	67	229	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	8hhq-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	8hhq-assembly1.cif.gz_B-2 Covalent bond formation between cysteine of PPARg-LBD and iodoacetic acid	0.074	175	145	26	200	90	247	6.140E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	4hee-assembly1.cif.gz_X	LOKIASV2_1571_ESMFold_hypothetical_protein	4hee-assembly1.cif.gz_X Crystal structure of PPARgamma in complex with compound 13	0.104	169	130	27	195	85	230	8.606E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1rdt-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	1rdt-assembly1.cif.gz_D Crystal Structure of a new rexinoid bound to the RXRalpha ligand binding doamin in the RXRalpha/PPARgamma heterodimer	0.097	178	160	29	206	63	240	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5f9b-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5f9b-assembly1.cif.gz_A X-ray crystal structure of PPARgamma in the complex with caulophyllogenin	0.107	174	134	26	199	89	239	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3ia6-assembly2.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	3ia6-assembly2.cif.gz_B-2 X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist	0.087	178	141	26	203	94	248	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7efq-assembly1.cif.gz_A Crystal structure of hPPARgamma ligand binding domain complexed with rosiglitazone-based fluorescence probe	0.079	172	141	27	198	91	244	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2vv1-assembly1.cif.gz_A hPPARgamma Ligand binding domain in complex with 4-HDHA	0.106	173	134	27	199	90	240	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3adt-assembly2.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	3adt-assembly2.cif.gz_B-2 Human PPARgamma ligand-binding domain in complex with 5-hydroxy-indole acetate	0.087	178	138	27	204	95	246	5.313E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_D-2	LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_D-2 Crystal Structure of PPARgamma in complex with SR1664	0.103	176	144	26	201	96	256	8.606E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	1nyx-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1nyx-assembly1.cif.gz_B Ligand binding domain of the human peroxisome proliferator activated receptor gamma in complex with an agonist	0.083	170	142	29	198	101	256	6.140E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	8bf1-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8bf1-assembly1.cif.gz_A High-resolution structure of unliganded PPAR gamma in complex with the peptide PGC-1 alpha	0.102	173	133	27	199	97	245	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3gz9-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3gz9-assembly1.cif.gz_A Crystal Structure of Peroxisome Proliferator-Activated Receptor Delta (PPARd) in Complex with a Full Agonist	0.086	171	131	29	199	102	245	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6c1i-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with T0070907	0.095	174	136	26	199	96	246	6.443E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_A PPARg LBD in Complex with SR1988	0.089	178	151	26	203	96	262	7.447E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	6d3e-assembly1.cif.gz_B-2 PPARg LBD in Complex with SR1988	0.116	178	136	26	203	100	254	8.201E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	8hhp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8hhp-assembly1.cif.gz_A Crystal structure of PPARg-LBD complexed with three partial agonists, one nTZDpa and two LT175	0.106	173	133	34	206	101	250	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3wmh-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3wmh-assembly1.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gammma selective synthetic partial agonist MEKT75	0.065	173	143	26	198	97	250	6.762E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3vsp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3vsp-assembly1.cif.gz_A Human PPAR gamma ligand binding domain in complex with a gamma selective agonist mekt28	0.108	181	140	26	206	98	255	8.606E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8b8x-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with SR10221, an inverse agonist	0.101	162	131	27	188	104	250	7.096E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6c5t-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6c5t-assembly1.cif.gz_A PPARg LBD bound to SR11023	0.102	171	133	30	200	106	254	8.606E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6t1s-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	6t1s-assembly1.cif.gz_A-2 PPAR mutant	0.095	178	136	27	204	107	257	5.851E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	4c9j-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4c9j-assembly1.cif.gz_A Structure of yeast mitochondrial ADP/ATP carrier isoform 3 inhibited by carboxyatractyloside (P212121 crystal form)	0.121	197	149	29	198	78	274	9.032E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbd-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6sbd-assembly1.cif.gz_A Structure of type II terpene cyclase MstE_D109A from Scytonema in complex with merosterolic acid A (product)	0.109	107	79	27	116	1	107	7.815E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	3dzy-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	3dzy-assembly1.cif.gz_D Intact PPAR gamma - RXR alpha Nuclear Receptor Complex on DNA bound with Rosiglitazone, 9-cis Retinoic Acid and NCOA2 Peptide	0.094	174	134	31	204	189	337	6.140E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	4zyr-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4zyr-assembly2.cif.gz_B Crystal structure of E. coli Lactose permease G46W/G262W bound to p-nitrophenyl alpha-D-galactopyranoside (alpha-NPG)	0.133	156	114	30	185	50	182	5.575E+00	19
LOKIASV2_1571_ESMFold_hypothetical_protein	5ww3-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5ww3-assembly1.cif.gz_A Crystal structure of the second DNA-Binding protein under starvation from Mycobacterium smegmatis soaked with iron in the ratio of 24 iron atoms per dodecamer	0.110	194	140	3	196	1	158	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6yj2-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6yj2-assembly1.cif.gz_A Structural and DNA binding studies of the transcriptional repressor Rv2506 (BkaR) from Mycobacterium tuberculosis supports a role in L-Leucine catabolism	0.166	132	104	66	191	3	134	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	4ozt-assembly1.cif.gz_U	LOKIASV2_1571_ESMFold_hypothetical_protein	4ozt-assembly1.cif.gz_U crystal structure of the ligand binding domains of the Bovicola ovis ecdysone receptor EcR/USP heterodimer (PonA crystal)	0.081	167	141	31	184	3	169	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.102	166	128	30	195	62	205	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q70-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain complxed to a benzopyran ligand	0.081	171	142	31	185	31	201	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly1.cif.gz_B Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists	0.110	173	151	28	200	40	210	6.140E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6a5z-assembly1.cif.gz_A Crystal structure of human FXR/RXR-LBD heterodimer bound to HNC180 and 9cRA and SRC1	0.109	155	133	29	183	47	196	8.201E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly2.cif.gz_D Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.099	199	159	25	201	22	220	6.443E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5q0m-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5q0m-assembly1.cif.gz_A Ligand binding to FARNESOID-X-RECEPTOR	0.094	144	120	45	188	75	208	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs9-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-25	0.097	176	138	30	205	58	211	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6c42-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6c42-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1156	0.072	175	149	26	187	27	201	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5dyd-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4,4'-{[(3S)-3-(methylsulfanyl)cyclohexylidene]methanediyl}diphenol	0.114	155	120	66	201	68	222	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6itm-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6itm-assembly1.cif.gz_A Crystal structure of FXR in complex with agonist XJ034	0.092	160	136	30	180	40	199	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	1lv2-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1lv2-assembly1.cif.gz_A Hepatocyte Nuclear Factor 4 is a Transcription Factor that Constitutively Binds Fatty Acids	0.102	179	138	28	206	61	215	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	5w9c-assembly2.cif.gz_D Estrogen Receptor Alpha Ligand Binding Domain C381S, C417S, C530S in Complex with 4-hydroxytamoxifen	0.082	183	149	25	187	26	208	6.140E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rrz-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.109	158	130	30	187	64	210	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	0.078	187	157	17	187	25	211	5.851E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujc-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujc-assembly1.cif.gz_A Raloxifene in Complex with Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutation	0.080	202	164	26	204	27	228	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	5wgq-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with Estradiol and SRC2-BCP1	0.098	177	139	24	200	60	214	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	0.078	167	149	34	200	55	217	9.032E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6owc-assembly1.cif.gz_A Mutant estrogen receptor alpha (ERa) Y537S covalently bound to H3B-6545.	0.094	206	159	25	201	26	231	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8du8-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6-hydroxy-1-(4-((1-propylazetidin-3-yl)oxy)phenyl)-3,4-dihydroisoquinolin-2(1H)-yl)(phenyl)methanone	0.072	184	149	26	187	29	212	6.140E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dfn-assembly1.cif.gz_A Crystal structure of estrogen receptor alpha in complex with receptor degrader 16aa	0.090	193	156	30	201	41	233	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs2-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-23	0.095	176	146	30	205	60	221	6.140E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6s4u-assembly1.cif.gz_A LXRbeta ligand binding domain in comlpex with small molecule inhibitors	0.095	227	161	27	205	3	229	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	4j5x-assembly1.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	4j5x-assembly1.cif.gz_D Crystal Structure of the SR12813-bound PXR/RXRalpha LBD Heterotetramer Complex	0.095	208	156	29	201	6	213	5.313E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	4rup-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	4rup-assembly1.cif.gz_A-2 Crystal structure of zVDR L337H mutant-Gemini72 complex	0.109	161	125	24	184	69	209	5.851E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1a52-assembly1.cif.gz_B ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED TO ESTRADIOL	0.081	179	152	27	205	67	232	9.947E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6sbo-assembly1.cif.gz_B Estrogen receptor mutant L536S	0.097	218	171	17	206	25	242	9.032E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	3b0r-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3b0r-assembly1.cif.gz_B Human PPAR gamma ligand binding dmain complexed with GW9662 in a covalent bonded form	0.073	172	139	29	200	94	244	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly2.cif.gz_E	LOKIASV2_1571_ESMFold_hypothetical_protein	5i4v-assembly2.cif.gz_E Discovery of novel, orally efficacious Liver X Receptor (LXR) beta agonists	0.070	236	166	27	205	4	239	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	3osi-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3osi-assembly2.cif.gz_B Crystal structure of PPARgamma ligand binding domain in complex with tetrachloro-bisphenol A (TCBPA)	0.080	168	137	27	194	85	234	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2q5p-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q5p-assembly1.cif.gz_B Crystal Structure of PPARgamma bound to partial agonist MRL24	0.096	168	138	27	194	87	240	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5tn1-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in Complex with the estradiol derivative, (8S,9S,13S,14S,E)-17-((4-isopropylphenyl)imino)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ol	0.072	201	165	22	200	30	230	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7e2o-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7e2o-assembly2.cif.gz_B X-ray Crystal structure of PPARgamma R288H mutant.	0.092	179	138	27	205	88	240	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	1nuo-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1nuo-assembly1.cif.gz_A Two RTH Mutants with Impaired Hormone Binding	0.112	171	139	30	200	89	246	8.201E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2vst-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2vst-assembly2.cif.gz_B hPPARgamma Ligand binding domain in complex with 13-(S)-HODE	0.078	176	141	29	204	95	248	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	1y2o-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1y2o-assembly1.cif.gz_B Structure of N-terminal domain IRSp53/BAIAP2	0.128	190	144	29	194	38	227	4.824E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2awh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2awh-assembly1.cif.gz_B Human Nuclear Receptor-Ligand Complex 1	0.095	162	126	26	187	83	222	8.606E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2zno-assembly2.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	2zno-assembly2.cif.gz_B-2 Human PPAR gamma ligand binding domain in complex with a synthetic agonist TIPP703	0.093	173	135	32	204	93	242	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2j14-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2j14-assembly1.cif.gz_A 3,4,5-Trisubstituted Isoxazoles as Novel PPARdelta Agonists: Part2	0.076	158	132	30	187	83	226	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2q8s-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2q8s-assembly1.cif.gz_B X-ray Crystal structure of the nuclear hormone receptor PPAR-gamma in a complex with a PPAR gamma/alpha dual agonist	0.091	176	145	26	201	93	253	7.096E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7cxe-assembly1.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	7cxe-assembly1.cif.gz_B-2 The ligand-free structure of human PPARgamma LBD R280C mutant	0.081	178	139	27	204	90	241	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone	0.105	172	136	32	203	96	248	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgl-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6dgl-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Darglitazone	0.104	176	142	26	201	96	255	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	1i7i-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1i7i-assembly2.cif.gz_B CRYSTAL STRUCTURE OF THE LIGAND BINDING DOMAIN OF HUMAN PPAR-GAMMA IN COMPLEX WITH THE AGONIST AZ 242	0.074	176	138	29	204	98	247	7.815E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	3sz1-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3sz1-assembly2.cif.gz_B Human PPAR gamma ligand binding domain in complex with luteolin and myristic acid	0.115	179	134	26	204	93	244	8.201E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2znn-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2znn-assembly1.cif.gz_A Human PPAR alpha ligand binding domain in complex with a synthetic agonist TIPP703	0.123	168	125	31	198	97	239	9.947E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	3et0-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3et0-assembly2.cif.gz_B Structure of PPARgamma with 3-(5-Methoxy-1H-indol-3-yl)-propionic acid	0.103	180	144	26	205	92	252	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	8huk-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8huk-assembly1.cif.gz_A X-ray structure of human PPAR alpha ligand binding domain-lanifibranor-SRC1 coactivator peptide co-crystals obtained by soaking	0.092	179	137	26	204	91	242	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	7e0a-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7e0a-assembly1.cif.gz_A X-ray structure of human PPARgamma ligand binding domain-saroglitazar co-crystals obtained by co-crystallization	0.111	178	134	29	206	106	257	8.201E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6fzf-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6fzf-assembly1.cif.gz_A PPAR mutant complex	0.109	179	135	26	204	103	254	9.478E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	8ium-assembly1.cif.gz_R	LOKIASV2_1571_ESMFold_hypothetical_protein	8ium-assembly1.cif.gz_R Cryo-EM structure of the tafluprost acid-bound human PTGFR-Gq complex	0.122	153	124	36	188	2	143	6.762E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	6sbe-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6sbe-assembly1.cif.gz_A Structure of type II terpene cyclase MstE_D109N from Scytonema in complex with geranylgeranyl dihydroxybenzoate (substrate)	0.087	127	110	27	153	1	122	5.575E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	2x0l-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2x0l-assembly1.cif.gz_A Crystal structure of a neuro-specific splicing variant of human histone lysine demethylase LSD1.	0.077	151	132	26	176	204	347	7.447E+00	18
LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_A Crystal structure of gated-pore mutant D138H of second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.103	191	138	6	196	3	157	9.032E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6cht-assembly2.cif.gz_H	LOKIASV2_1571_ESMFold_hypothetical_protein	6cht-assembly2.cif.gz_H HNF4alpha in complex with the corepressor EBP1 fragment	0.078	175	144	27	201	38	194	6.140E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7vg5-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7vg5-assembly1.cif.gz_B 10,5-methenyltetrahydrofolate cyclohydrolase from Methylobacterium extorquens AM1 with tetrahydrofolate	0.175	179	135	30	194	19	197	5.575E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7e1n-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7e1n-assembly1.cif.gz_B Crystal structure of PhlH in complex with 2,4-diacetylphloroglucinol	0.129	165	134	30	194	49	203	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujw-assembly2.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain Y537S Mutant in Complex with a Methylated Lasofoxifene Derivative that Possesses Selective Estrogen Receptor Degrader Activities	0.101	188	157	25	200	22	209	7.815E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	3l1b-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3l1b-assembly1.cif.gz_A Complex Structure of FXR Ligand-binding domain with a tetrahydroazepinoindole compound	0.105	183	155	29	202	34	216	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	1pq9-assembly2.cif.gz_D HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 COMPLEX	0.094	204	159	29	205	10	213	7.815E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2r6y-assembly1.cif.gz_B Estrogen receptor alpha ligand-binding domain in complex with a SERM	0.109	171	151	30	200	50	220	7.815E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7rry-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-20	0.101	186	146	25	187	23	208	9.032E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	3ols-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3ols-assembly2.cif.gz_B Crystal structure of estrogen receptor beta ligand binding domain	0.067	172	133	30	201	69	212	8.606E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	5y44-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5y44-assembly1.cif.gz_A A novel moderator XD4 for bile acid receptor	0.074	166	147	21	180	31	196	8.606E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7msa-assembly1.cif.gz_A GDC-9545 in complex with estrogen receptor alpha	0.088	167	143	30	187	41	207	7.096E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	8dug-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8dug-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (6'-hydroxy-1'-(4-(2-((<i>S</i>)-3-methylpyrrolidin-1-yl)ethoxy)phenyl)-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.079	181	148	24	185	23	203	7.815E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8dui-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-(2-(dimethylamino)ethoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.088	158	128	30	187	67	207	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	5tnb-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S,L536S) in Complex with the OBHS-BSC, 4-bromophenyl (1R,2R,4S)-6-(4-(2-(dimethylamino)ethoxy)phenyl)-5-(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hept-5-ene-2-sulfonate	0.114	186	152	30	201	41	226	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	1u3s-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1u3s-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor beta complexed with WAY-797	0.075	175	158	30	201	39	213	8.201E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	4is8-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4is8-assembly2.cif.gz_B Divergent sequence tunes ligand sensitivity in phospholipid-regulated hormone receptors	0.092	193	163	20	200	28	220	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	2qa8-assembly1.cif.gz_A Crystal Structure of the Estrogen Receptor Alpha Ligand Binding Domain Mutant 537S Complexed with Genistein	0.052	180	160	31	200	36	215	8.606E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	1u3r-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	1u3r-assembly1.cif.gz_A Crystal Structure of Estrogen Receptor beta complexed with WAY-338	0.058	176	161	30	201	39	214	7.096E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7ndo-assembly1.cif.gz_B ER-PRS*(-) (L536S, L372R) in complex with raloxifene	0.079	192	156	18	187	21	212	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	8dvb-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8dvb-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with (1'-(4-((1-butylpyrrolidin-3-yl)methoxy)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.083	192	154	19	187	24	215	7.447E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2	LOKIASV2_1571_ESMFold_hypothetical_protein	7ujo-assembly2.cif.gz_D-2 Estrogen Receptor Alpha Ligand Binding Domain in Complex with RU39411	0.076	202	172	19	205	25	226	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7kbs-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with Raloxifene	0.097	192	152	19	187	24	215	8.201E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs7-assembly2.cif.gz_C Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-30	0.090	212	166	19	201	26	237	7.096E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	6k9m-assembly2.cif.gz_D Human LXR-beta in complex with an agonist	0.098	159	123	27	185	71	207	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	1zeo-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	1zeo-assembly1.cif.gz_B Crystal Structure of Human PPAR-gamma Ligand Binding Domain Complexed with an Alpha-Aryloxyphenylacetic Acid Agonist	0.097	175	144	27	201	86	246	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_A Human LXR-beta in complex with an agonist	0.052	246	170	26	205	1	246	8.201E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	3po9-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3po9-assembly2.cif.gz_B Crystal structure of PPARgamma ligand binding domain in complex with tripropyltin	0.092	175	143	26	200	86	244	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	4r06-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4r06-assembly1.cif.gz_A Crystal Structure of SR2067 bound to PPARgamma	0.087	179	138	26	204	86	237	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6an1-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6an1-assembly1.cif.gz_B Crystal structure of the complex between PPARgamma LBD and the ligand AM-879	0.078	162	131	26	187	93	235	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	8b8y-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8b8y-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 7e)	0.112	172	132	28	199	98	247	9.032E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6icj-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6icj-assembly1.cif.gz_A Crystal structure of PPARgamma with compound BR102375K	0.116	176	132	29	204	89	238	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	3cwd-assembly1.cif.gz_A Molecular recognition of nitro-fatty acids by PPAR gamma	0.093	179	137	26	204	89	240	8.606E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6md1-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6md1-assembly2.cif.gz_B Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with GW9662 and Oleic acid	0.081	176	148	26	201	95	256	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	7bq2-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	7bq2-assembly1.cif.gz_A X-ray structure of human PPARalpha ligand binding domain-pemafibrate-SRC1 coactivator peptide co-crystals obtained by soaking	0.103	179	135	26	204	91	242	9.478E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6dbh-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	6dbh-assembly2.cif.gz_B Crystal structure of PPAR gamma in complex with NMP422	0.085	179	138	26	204	97	248	8.606E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6dgo-assembly1.cif.gz_A Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Troglitazone	0.111	166	128	34	199	101	245	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	8dsz-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8dsz-assembly1.cif.gz_B PPARg bound to partial agonist H3B-487	0.084	162	130	26	187	95	237	9.032E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	2zk1-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	2zk1-assembly1.cif.gz_B Human peroxisome proliferator-activated receptor gamma ligand binding domain complexed with 15-deoxy-delta12,14-prostaglandin J2	0.098	179	136	26	204	103	254	9.032E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	3ncy-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	3ncy-assembly1.cif.gz_B X-ray crystal structure of an arginine agmatine antiporter (AdiC) in complex with a Fab fragment	0.125	124	106	80	201	278	401	9.947E+00	17
LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	4m34-assembly1.cif.gz_C Crystal structure of gated-pore mutant D138H of second DNA-Binding protein under starvation from Mycobacterium smegmatis	0.109	179	135	18	196	2	153	9.478E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	7jg5-assembly1.cif.gz_a	LOKIASV2_1571_ESMFold_hypothetical_protein	7jg5-assembly1.cif.gz_a Cryo-EM structure of bedaquiline-free Mycobacterium smegmatis ATP synthase rotational state 1	0.135	159	130	27	185	56	206	5.313E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D	LOKIASV2_1571_ESMFold_hypothetical_protein	7rs8-assembly2.cif.gz_D Crystal Structure of the ER-alpha Ligand-binding Domain (L372S, L536S) in complex with DMERI-16	0.086	169	143	25	181	25	193	9.947E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5dxp-assembly1.cif.gz_A Crystal Structure of the ER-alpha Ligand-binding Domain in Complex with the Cyclofenil Derivative 4-[(E)-(1s,5s)-bicyclo[3.3.1]non-9-ylidene(phenyl)methyl]phenol	0.064	179	164	31	206	34	212	9.478E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	7qvl-assembly2.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	7qvl-assembly2.cif.gz_B OESTROGEN RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH COMPOUND 38	0.090	171	142	30	200	57	213	8.201E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	4znh-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	4znh-assembly1.cif.gz_B Crystal Structure of the ER-alpha Ligand-binding Domain (Y537S) in complex with a 2-Fluoro-substituted OBHS derivative	0.085	176	148	26	201	62	224	9.947E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	5ufw-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5ufw-assembly1.cif.gz_A Estrogen Receptor Alpha Ligand Binding Domain in Complex with OP1154	0.089	188	150	19	184	22	209	9.032E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	8b93-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	8b93-assembly1.cif.gz_A Crystal structure of PPARG and NCOR2 with an inverse agonist (compound 15b)	0.098	178	135	27	204	97	247	9.947E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	5kyj-assembly1.cif.gz_A Brain penetrant liver X receptor (LXR) modulators based on a 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole core	0.079	245	167	24	205	1	245	9.478E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	4r6s-assembly2.cif.gz_B-2	LOKIASV2_1571_ESMFold_hypothetical_protein	4r6s-assembly2.cif.gz_B-2 Crystal structure of PPARgammma in complex with SR1663	0.073	179	140	26	204	93	244	9.478E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	6wh4-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6wh4-assembly1.cif.gz_A Crystal structure of HTR2A with inverse agonist	0.114	175	128	30	204	2	147	6.140E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	6p25-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6p25-assembly1.cif.gz_A Structure of S. cerevisiae protein O-mannosyltransferase Pmt1-Pmt2 complex bound to the sugar donor and a peptide acceptor	0.129	158	136	29	185	125	282	3.977E+00	16
LOKIASV2_1571_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B	LOKIASV2_1571_ESMFold_hypothetical_protein	8dub-assembly1.cif.gz_B Estrogen Receptor Alpha Ligand Binding Domain in Complex with ((1'-(4-((1-ethylpyrrolidin-3-yl)methyl)phenyl)-6'-hydroxy-1',4'-dihydro-2'<i>H</i>-spiro[cyclopropane-1,3'-isoquinolin]-2'-yl)(phenyl)methanone	0.074	175	144	25	181	20	194	9.947E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	6k9g-assembly1.cif.gz_C Human LXR-beta in complex with an agonist	0.079	206	158	29	201	11	216	9.947E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly1.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	6jio-assembly1.cif.gz_A Human LXR-beta in complex with a ligand	0.084	207	148	26	188	3	209	8.606E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_A	LOKIASV2_1571_ESMFold_hypothetical_protein	4r2u-assembly2.cif.gz_A Crystal Structure of PPARgamma in complex with SR1664	0.078	179	139	26	204	93	244	9.478E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	2efk-assembly1.cif.gz_A-2	LOKIASV2_1571_ESMFold_hypothetical_protein	2efk-assembly1.cif.gz_A-2 Crystal structure of the EFC domain of Cdc42-interacting protein 4	0.119	227	152	29	201	12	238	4.597E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	5x5y-assembly1.cif.gz_G	LOKIASV2_1571_ESMFold_hypothetical_protein	5x5y-assembly1.cif.gz_G A membrane protein complex	0.122	176	113	29	204	10	139	9.947E+00	15
LOKIASV2_1571_ESMFold_hypothetical_protein	3gi8-assembly1.cif.gz_C	LOKIASV2_1571_ESMFold_hypothetical_protein	3gi8-assembly1.cif.gz_C Crystal Structure of ApcT K158A Transporter Bound to 7F11 Monoclonal Fab Fragment	0.103	199	140	30	186	43	241	9.947E+00	14
